Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
1(10%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
2
20%
Ph not_applicable
3
30%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution5 total trials
Phase 4Post-market surveillance
2(40.0%)
N/ANon-phased studies
3(60.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

10

all time

Status Distribution
Active(1)
Completed(5)
Other(4)

Detailed Status

Completed5
unknown4
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 42 (40.0%)
N/A3 (60.0%)

Trials by Status

completed550%
recruiting110%
unknown440%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
DEVICE
Total Trials
10